That sounds most logical. I wish we knew the terms of the licensing agreement...what does tclt get in return, I wonder? I still think most logically they'd get royalties from such a deal. This could be a big winner in the months to come...why wouldn't this product be courted by a large pharmaceutical company...it works and is getting third party confirmation of it's efficacy from well-known athletes.
We might see more dilution before that happens, but I'm willing to hold my shares at .0003. It won't break me, and it could multiply by ten or more soon. The possibilities are excellent.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.